All Publications

Export 170 results:
Author Title Type [ Year(Asc)]
2019
Virological outcomes of boosted protease inhibitor-based first-line ART in subjects harbouring thymidine analogue-associated mutations as the sole form of transmitted drug resistance. Geretti A, White E, Orkin C, Tostevin A, Tilston P, Chadwick D, Leen C, Sabin C and Dunn D. J Antimicrobial Chemother, Volume 74, p.746-53., (2019)
2018
The association between detected drug resistance mutations and CD4+ T-cell decline in HIV-positive individuals maintained on a failing treatment regimen. Schultze A, Paredes R, Sabin C, Phillips A, Pillay D, Mackie N, Castagna A, Chadwick D, Falconer K, Geretti A et al. Antivir Ther, Volume 23, p.105-116, (2018)
Chronic kidney disease in HIV populations of African descent in the UK. Jose S, Hamzah L, Jones R, Williams D, Winston A, Burns F, Sabin C and Post F. Conference on Retroviruses and Opportunistic Infections, Volume Top Antivir Med. 2018; 26(suppl 1):319s, p.CROI Abstract 731, (2018)
Chronic kidney disease risk in African and Caribbean populations with HIV. Jose S, Hamzah L, Jones R, Williams D, Winston A, Burns F, Phillips A, Sabin C and UK CHIC Study. J Inf Dis, (2018)
A continuum of HIV care describing mortality and loss to follow-up; a longitudinal cohort study. Jose S, Delpech V, Howarth A, Burns F, Hill T, Porter K, Sabin C and UK CHIC Study Steering Committee. Lancet HIV, (2018)
Effect of immediate initiation of antiretroviral treatment on the risk of acquired HIV drug resistance. The HIV-CAUSAL Collaboration. Lodi S, Gunthard H, Dunn D, Garcia F, Logan R, Jose S, Bucher H, Scherrer A, Schneider M, Egger M et al. AIDS, Volume 32, p.327-335., (2018)
Global Trends in CD4 Cell Count at the Start of Antiretroviral Therapy: Collaborative Study of Treatment Programs. IeDEA and COHERE Cohort Collaboration. . Clin Infect Dis, Volume 66, Issue 6, p.893-903, (2018)
Liver ultrasound to evaluate patients with HIV and hepatitis B/C co-infection: coverage and findings from the UK CHIC Study. Garvey L, Jose S, Thornton A, Rodger A, Baghani S, Gilson R, Main J, Taylor C, Dunn D, Chadwick D et al. 4th Joint Conference of British HIV Association (BHIVA) with BASHH, Volume HIV Medicine 2018; 19 (Suppl. 2), s21-s152, p.Poster P394, (2018)
Results of HIV-1 drug resistance tests performed in ART-experienced patients in the UK: patterns 2008-2015. Tostevin A, Dunn D, Stirrup O, Mackie N, Asboe D, Posniak A, Churchill D, Leigh-Brown A, Sabin C, Smit E et al. 4th Joint Conference of the British HIV Association (BHIVA) with BASHH, Volume HIV Medicine 2018; 19 (Suppl. 2), s21-s152, p.Poster P363, (2018)
Risk factors and outcomes for the Q151M and T69 insertion HIV-1 resistance mutations in historic UK data. UK HIV Drug Resistance Database; UK Collaborative HIV Cohort. Stirrup O, Dunn D, Tostevin A, Sabin C, Pozniak A, Asboe D, Cox A, Orkin C, Martin F and Cane P. AIDS Res Ther, Volume 15, p.11, (2018)
The use of funnel plots with regression as a tool to visually compare HIV treatment outcomes between centres adjusting for patient characteristics and size: a UK Collaborative HIV Cohort study. Gompels M, Michael S, Jose S, Hill T, Trevelion R, Sabin C and May M. HIV Medicine, (2018)
2017
Association between engagement in-care and mortality in HIV-positive persons. Sabin C, Howarth A, Jose S, Hill T, Apea V, Morris S and Burns F. AIDS, 2017 Mar 13, Volume 31, Issue 5, p.653-660, (2017)
An association between K65R and HIV-1 subtype C viruses in patients treated with multiple NRTIs. Smit E, White E, Clark D, Churchill D, Zhang H, Collins S, Pillay D, Sabin C, Nelson M, Winston A et al. Antimicrob Chemother, Volume 72, p.2075-82., (2017)
Chronic Hepatitis B and C Virus Infection and Risk for Non-Hodgkin Lymphoma in HIV-Infected Patients: A Cohort Study. Wang Q, De Luca A, Smith C, Zangerle R, Sambatakou H, Bonnet F, Smit C, Schommers P, Thornton A, Berenguer J et al. Ann Intern Med, 2017 01 03, Volume 166, Issue 1, p.9-17, (2017)
Cirrhosis and liver transplantation in patients co-infected with HIV and hepatitis B or C: an observational cohort study. Warren-Gash C, Childs K, Thornton A, Bhagani S, Demma S, Srivastava A, Leen C, Agarwal K, Rodger A and Sabin C. Infection, 2017 Apr, Volume 45, Issue 2, p.215-220, (2017)
Development and application of a new measure of engagement in out-patient HIV care. Howarth A, Burns F, Apea V, Jose S, Hill T, Delpech V, Evans A, Mercer C, Michie S, Morris S et al. HIV Med, 2017 Apr, Volume 18, Issue 4, p.267-274, (2017)
Durability of viral suppression with first-line antiretroviral therapy in patients with HIV in the UK: an observational cohort study. O'Connor J, Smith C, Lampe F, Johnson M, Chadwick D, Nelson M, Dunn D, Winston A, Post F, Sabin C et al. Lancet HIV, 2017 May 04, (2017)
Effect of immediate initiation of antiretroviral treatment in HIV-positive individuals aged 50 years or older. The HIV-CAUSAL Collaboration. Lodi S, Costagliola D, Sabin C, Del Amo J, Logan R, Abgrall S, Reiss P, van Sighem A, Jose S, Blanco J et al. J Acquir Immune Defic Syndr, Volume 76, p.311-318, (2017)
Factors associated with rapid eGFR decline in patients receiving TDF and/or ATV. Hamzah L, Jose S, Jones R, Williams D, Chadwick D, Phillips A, Sabin C and Post F. CROI 2017, Volume Top Antivir Med. 2017;25(supp 1):273s, p.Abstract 650 Poster, (2017)
Growing up with perinatal HIV: changes in clinical outcomes before and after transfer to adult care in the UK. Judd A, Collins I, Parrott F, Hill T, Jose S, Ford D, Asad H, Gibb D and Sabin C. J Int AIDS Soc, 2017 May 16, Volume 20, Issue Suppl 3, p.71-80, (2017)
Hepatitis B, hepatitis C, and mortality among HIV-positive individuals. Thornton A, Jose S, Bhagani S, Chadwick D, Dunn D, Gilson R, Main J, Nelson M, Rodger A, Taylor C et al. AIDS, Volume 31, p.2525-32, (2017)
Improved kidney function in patients who switch their protease inhibitor from atazanavir or lopinavir to darunavir. Jose S, Nelson M, Phillips A, Chadwick D, Trevelion R, Jones R, Williams D, Hamzah L, Sabin C and Post F. AIDS, 2017 Feb 20, Volume 31, Issue 4, p.485-492, (2017)
REACH: a mixed-methods study to investigate the measurement, prediction and improvement of retention and engagement in outpatient HIV care. Howarth A, Apea V, Michie S, Morris S, Sachikonye M, Mercer C, Evans A, Delpech V, Sabin C and Burns F. Health Services and Delivery Research, Volume 5, Issue 13, (2017)
Reference curves for CD4 T-cell count response to combination antiretroviral therapy in HIV-1-infected treatment-naïve patients. Bouteloup V, Sabin C, Mocroft A, Gras L, Pantazis N, Le Moing V, Monforte A, Mary-Krause M, Roca B, Miro J et al. HIV Med, 2017 Jan, Volume 18, Issue 1, p.33-44, (2017)
A tale of two countries: all-cause mortality among people living with HIV and receiving combination antiretroviral therapy in the UK and Canada. Patterson S, Jose S, Samji H, Cescon A, Ding E, Zhu J, Anderson J, Burchell A, Cooper C, Hill T et al. HIV Med, 2017 Apr 24, (2017)